These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33843539)

  • 41. [The status of vaccine preventable diseases in Germany].
    Oppermann H
    Gesundheitswesen; 2001 Feb; 63(2):102-6. PubMed ID: 11285747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Infectious diseases epidemiology in Germany].
    Dierich MP; Ammon A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):961-2. PubMed ID: 16160882
    [No Abstract]   [Full Text] [Related]  

  • 43. Communication Between Infectious Disease Physicians and US State and Local Public Health Agencies: Strengths, Challenges, and Opportunities.
    Santibañez S; Polgreen PM; Beekmann SE; Cairns C; Filice GA; Layton M; Hughes JM
    Public Health Rep; 2016 Sep; 131(5):666-670. PubMed ID: 28123206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of public health service in prevention and control of infectious diseases in the Federal Republic of Germany. Tasks, structures and responsibilities--an overview].
    Wirtz A; Andres M; Gottschalk R; Stark S; Weber HJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):971-8. PubMed ID: 16160884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multinational Disease Surveillance Programs: Promoting Global Information Exchange for Infectious Diseases.
    Varan AK; Bruniera-Oliveira R; Peter CR; Fonseca-Ford M; Waterman SH
    Am J Trop Med Hyg; 2015 Sep; 93(3):668-71. PubMed ID: 26033019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Infectious disease epidemiology education and training Programs. FETP and EPIET].
    Bremer V
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):1049-54. PubMed ID: 16160894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study.
    Hager T; Kraywinkel K; Szarvas T; Hadaschik B; Schmid KW; Reis H
    Urol Int; 2020; 104(9-10):803-809. PubMed ID: 32784300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infectious diseases in Poland in 2016.
    Sadkowska-Todys M; Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2018; 72(2):129-141. PubMed ID: 30111085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The epidemiologic situation of infectious disease in West Germany in 1979].
    Pöhn HP
    Fortschr Med; 1981 Mar; 99(9):285-8. PubMed ID: 7216110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. The EMERGEncy ID NET Study Group.
    Talan DA; Moran GJ; Mower WR; Newdow M; Ong S; Slutsker L; Jarvis WR; Conn LA; Pinner RW
    Ann Emerg Med; 1998 Dec; 32(6):703-11. PubMed ID: 9832668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Principles of epidemic emergency preparedness planning: the example of the German Influenza Pandemic Preparedness Plan].
    Haas WH
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):1020-7. PubMed ID: 16160890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [On the 2007 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Poggensee G; Benzler J; Eckmanns T; Krause G;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Dec; 49(12):1189-94. PubMed ID: 17149664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ID-Viewer: a visual analytics architecture for infectious diseases surveillance and response management in Pakistan.
    Ali MA; Ahsan Z; Amin M; Latif S; Ayyaz A; Ayyaz MN
    Public Health; 2016 May; 134():72-85. PubMed ID: 26880489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [AIDS prevention in Germany].
    Pott E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Apr; 50(4):422-31. PubMed ID: 17387442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Panel 2.18: logistics, information technology (IT), and telecommunications in crisis management.
    De Silva T; Chikersal J; Snoad N; Woodworth B; Ghaly C; Catterall M
    Prehosp Disaster Med; 2005; 20(6):464-7. PubMed ID: 16496638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Civil society stakeholders' participation in national health reporting on sex/gender issues: a study protocol for an intersectionality-informed and sex/gender-sensitive approach to focus group research.
    Pöge K; Strasser SM; Saß AC; Rommel A
    BMJ Open; 2020 Jan; 10(1):e033412. PubMed ID: 31937654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prioritisation of infectious diseases in public health--call for comments.
    Krause G;
    Euro Surveill; 2008 Oct; 13(40):. PubMed ID: 18831949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectious disease specialist telephone consultations requested by general practitioners.
    Bal G; Sellier E; Gennai S; Caillis M; François P; Pavese P
    Scand J Infect Dis; 2011 Dec; 43(11-12):912-7. PubMed ID: 21867475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevalence and public-health-aspects of toxoplasmosis].
    Gross U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jul; 47(7):692-7. PubMed ID: 15254825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.